Archives

by in
Entry Author Date Location
Genentech Follows Fast at ASCO as Cancer Immunotherapy Picks Up 05/15/13 San Francisco
Dendreon Shares Fall Again, as Provenge Sales Slump 05/09/13 Seattle
Medivation Wins FDA Approval of Prostate Cancer Drug 08/31/12 San Francisco
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
OncoGenex Waits, and Waits, For Data on Prostate Cancer Drug 08/02/12 Seattle
Dendreon Cutting 600 Jobs, Closing NJ Plant As Sales Fall Short 07/30/12 Seattle
Dendreon Shareholders Vent at Annual Meeting 06/13/12 Seattle
Emerging Challenges of Prostate Cancer Drug Development 06/06/12 National
Medivation Emerges With New Prostate Cancer Drug 05/31/12 San Francisco
Dendreon’s Provenge Works Best for Patients With Low PSA, Scientists Say 05/16/12 Seattle
NY’s Cancer Research Institute Looks to Boost Cancer Immunotherapy 05/09/12 New York
Dendreon Meets Expectations with $82M in 1st Quarter Provenge Sales 05/07/12 Seattle
Analyst: Dendreon’s Growth Stalling With Cancer Docs as Rival Gains 05/04/12 Seattle
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
J&J Prostate Cancer Drug Hits Goal; Hurts Dendreon, Helps Medivation 03/08/12 New York
Dendreon Adds ImClone Vets to New Management Team 02/28/12 Seattle
Dendreon Stock Tumbles As Company Projects ‘Moderate’ Sales Growth 02/27/12 Seattle
Dendreon Names John Johnson CEO After Volatile Year 02/01/12 Seattle
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms 01/05/12 Seattle
Dendreon Pulls In $125M By Selling Royalty Slice of Merck’s Hepatitis C Drug 12/06/11 Seattle
Medivation, Astellas Prostate Cancer Drug Helps Men Live Longer; Shares Skyrocket 11/03/11 San Francisco
Dendreon Shares Tank Again, Elias Joins Gates Foundation, Seattle Children’s Gets $50M, & More Seattle-Area Life Sciences News 11/03/11 Seattle
Dendreon Edges Past Street Expectations With Third Quarter Provenge Sales, Shares Still Fall 11/02/11 Seattle
Chris Henney, the Immunex and Dendreon Mover/Shaker, Makes Biotech Hall of Fame 10/17/11 Seattle
Dendreon Concentrates Job Cuts in Manufacturing, but Seattle Feels the Axe Too 09/08/11 Seattle
Dendreon Whacks 500 Jobs, 25% of Workforce, After Missing Sales Goal 09/08/11 Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Dendreon Wins FDA OK for Atlanta Provenge Factory, Completing National Network 08/26/11 Seattle
Dendreon Adds Ex-ImClone CEO to Board 08/22/11 Seattle
Page 1 of 6 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.